XYL
41
-13
IRM
41
3
NTRS
35
-14
GOOG
87
6
PWR
67
5
FLR
52
4
BA
65
2
CCL
72
2
LB
9
-3
HAL
41
2
GIS
34
-3
UA
56
3
RHI
59
2
XOM
37
-2
NVDA
54
3
A
41
-3
SYF
86
3
EL
37
-3
CI
36
-4
ECL
57
-2
XYL
41
-13
IRM
41
3
NTRS
35
-14
GOOG
87
6
PWR
67
5
FLR
52
4
BA
65
2
CCL
72
2
LB
9
-3
HAL
41
2
GIS
34
-3
UA
56
3
RHI
59
2
XOM
37
-2
NVDA
54
3
A
41
-3
SYF
86
3
EL
37
-3
CI
36
-4
ECL
57
-2
Financhill
Back

Novonesis (Novozymes) B Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
53

NVZMF
Novonesis (Novozymes) B

Last Price:
59.08
Seasonality Move:
3.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Novonesis (Novozymes) B Price Quote

$59.08

Novonesis (Novozymes) B Key Stats

Buy
53
Novonesis (Novozymes) B (NVZMF) is a Buy
Day range:
$59.08 - $59.08
52-week range:
$49.89 - $71.52
Dividend yield:
2%
P/E ratio:
37.34
P/S ratio:
0.00
P/B ratio:
2.33%
Volume:
42
Avg. volume:
614
1-year change:
14.36%
Market cap:
$27.4B
Revenue:
$2.6B
EPS:
$1.58

How Much Does Novonesis (Novozymes) B Make?

Is Novonesis (Novozymes) B Growing As A Company?

Novonesis (Novozymes) B Stock Price Performance

What Is Novonesis (Novozymes) B 52-Week High & Low?

Novonesis (Novozymes) B Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Novonesis (Novozymes) B?

Is Novonesis (Novozymes) B Cash Flow Positive?

  • What Is NVZMF Cash Flow From Operations?
    Cash flow from operations (TTM) is $603.7M
  • What Is Novonesis (Novozymes) B’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$274.7M
  • What Is Novonesis (Novozymes) B’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$310.2M

Novonesis (Novozymes) B Return On Invested Capital

  • Is Management Doing A Good Job?
    NVZMF return on invested capital is 17.95%
  • What Is Novonesis (Novozymes) B Return On Assets?
    ROA measures how assets are converting to revenues and is 10.72%
  • What Is NVZMF Return On Equity?
    ROE is a measure of profitability and is 21.49%

Novonesis (Novozymes) B Earnings Date & Stock Price

Novonesis (Novozymes) B Competitors

Novonesis (Novozymes) B Dividend Yield

Novonesis (Novozymes) B Analyst Estimates

YoY Growth Past Surprise
EPS: -15.23% 0%
Revenue: 8.92% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many NVZMF shares are owned by institutional investors?
    118.2M NVZMF shares are owned by institutional investors
  • How many NVZMF shares are owned by insiders?
    0 NVZMF shares are owned by insiders